Abstract
Raman spectroscopy is a promising technique for the identification and analysis of molecules in a sample without any labeling or modification. Since Raman scattering spectra provide information about intracellular molecular distributions, metabolism and chemical reactions, Raman microscopy has been widely utilized for bio-imaging and biofunctional analysis. By using metallic nanostructures, Raman scattering from molecules at the vicinity of a metal surface is significantly enhanced, which is called surface-enhanced Raman scattering (SERS). Due to localized field enhancement, the highly sensitive detection of molecules can be achieved and many attempts to apply it for biological and biomedical research have been made. In this article, we review the applications of metallic nanoparticles as SERS agents for molecular analysis and imaging of biological cells and tissues.
Keywords: Surface enhanced raman scattering, metallic nanoparticles, raman microscopy, biomolecular imaging, plasmonics, biophysics and biomedical science
Current Pharmaceutical Biotechnology
Title:Metallic Nanoparticles as SERS Agents for Biomolecular Imaging
Volume: 14 Issue: 2
Author(s): Jun Ando and Katsumasa Fujita
Affiliation:
Keywords: Surface enhanced raman scattering, metallic nanoparticles, raman microscopy, biomolecular imaging, plasmonics, biophysics and biomedical science
Abstract: Raman spectroscopy is a promising technique for the identification and analysis of molecules in a sample without any labeling or modification. Since Raman scattering spectra provide information about intracellular molecular distributions, metabolism and chemical reactions, Raman microscopy has been widely utilized for bio-imaging and biofunctional analysis. By using metallic nanostructures, Raman scattering from molecules at the vicinity of a metal surface is significantly enhanced, which is called surface-enhanced Raman scattering (SERS). Due to localized field enhancement, the highly sensitive detection of molecules can be achieved and many attempts to apply it for biological and biomedical research have been made. In this article, we review the applications of metallic nanoparticles as SERS agents for molecular analysis and imaging of biological cells and tissues.
Export Options
About this article
Cite this article as:
Ando Jun and Fujita Katsumasa, Metallic Nanoparticles as SERS Agents for Biomolecular Imaging, Current Pharmaceutical Biotechnology 2013; 14 (2) . https://dx.doi.org/10.2174/1389201011314020003
DOI https://dx.doi.org/10.2174/1389201011314020003 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry Recent Patents on Genes and Gene Sequences Useful for Developing Breast Cancer Detection Systems
Recent Patents on DNA & Gene Sequences TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Current Medicinal Chemistry Strategic Aspects of NPY-Based Monoclonal Antibodies for Diagnosis and Treatment of Breast Cancer
Current Protein & Peptide Science Nanocarriers for Photodynamic Therapy Intended to Cutaneous Tumors
Current Drug Targets Airway Fibroblast Secretory Products Enhance Cell Migration
Current Proteomics Expression and Function of PPARs in Cancer Stem Cells
Current Stem Cell Research & Therapy Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)
Current Cancer Drug Targets Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Profilin 1 Potentiates Apoptosis Induced by Staurosporine in Cancer Cells
Current Molecular Medicine Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Liquid-Crystalline Nanodispersions Containing Monoolein for Photodynamic Therapy of Skin Diseases: A Mini-Review
Current Nanoscience Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Current Gene Therapy Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Cellular Senescence in the Development and Treatment of Cancer
Current Pharmaceutical Design Comparative Studies of the Chromogranin A-Derived Neuropeptide WE-14
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors
Current Cancer Therapy Reviews Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery